Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
APPA [NASD]
AP Pharma Inc.
Healthcare - Drug Manufacturers - Major - USA
Index- P/E- EPS (ttm)-0.39 Insider Own7.36% Shs Outstand39.38M Perf Week23.13%
Market Cap64.98M Forward P/E- EPS next Y- Insider Trans13.18% Shs Float36.48M Perf Month8.55%
Income-11.98M PEG- EPS next Q- Inst Own27.42% Short Float0.44% Perf Quarter75.53%
Sales1.16M P/S56.01 EPS this Y27.41% Inst Trans0.37% Short Ratio1.00 Perf Half Y94.12%
Book/sh0.01 P/B165.00 EPS next Y- ROA-113.60% Target Price2.50 Perf Year135.71%
Cash/sh0.04 P/C40.36 EPS next 5Y- ROE-203.48% 52W Range0.38 - 1.85 Perf YTD30.95%
Dividend- P/FCF- EPS past 5Y-43.36% ROI-184.34% 52W High-10.81% Beta0.93
Dividend %- Quick Ratio0.96 Sales past 5Y-40.26% Gross Margin- 52W Low334.21% ATR0.15
Employees33 Current Ratio0.96 Sales Q/Q1645.31% Oper. Margin-1033.13% RSI (14)71.00 Volatility13.91% 10.36%
OptionableNo Debt/Eq0.00 EPS Q/Q80.57% Profit Margin-1033.74% Rel Volume2.67 Prev Close1.66
ShortableYes LT Debt/Eq0.00 EarningsNov 05 BMO Payout- Avg Volume160.06K Price1.65
Recom1.00 SMA2016.32% SMA5036.14% SMA20077.75% Volume427,972 Change-0.60%
10-Sep-08Initiated Ladenburg Thalmann Buy $2.50
12-Jul-07Initiated Dawson James Speculative Buy
18-Jan-10 03:22AM  Biotech's Busy Week of Handshakes and Financings at Seeking Alpha
11-Jan-10 01:53PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events EDGAR Online
10:05AM  A.P. Pharma gets $2.5M milestone payment, regains Nasdaq compliance at bizjournals.com
06:17AM  InPlay: AP Pharma announces it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare Briefing.com
06:02AM  A.P. Pharma Receives $2.5 Million Milestone Payment Business Wire
06:00AM  A.P. Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule Business Wire
24-Nov-09 01:55PM  AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard EDGAR Online
23-Nov-09 06:00AM  A.P. Pharma Receives Notice of Compliance with Nasdaq Continued Listing Requirements Business Wire
20-Nov-09 01:04PM  AP PHARMA INC /DE/ Financials EDGAR Online Financials
16-Nov-09 03:24PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online -5.26%
03:17PM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
10:05AM  A.P. Pharma Q3 loss narrows to $1.2M at bizjournals.com
06:00AM  A.P. Pharma Reports Third Quarter 2009 Financial Results Business Wire
02-Nov-09 12:56PM  CEO Interview: Alexza Pharmaceuticals, Inc. - Thomas B. King Wall Street Transcript
28-Oct-09 02:01PM  AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard EDGAR Online
06:00AM  A.P. Pharma to Transfer to Nasdaq Capital Market Business Wire
22-Oct-09 04:45PM  AP PHARMA INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi EDGAR Online
20-Oct-09 11:05AM  AP Pharma raises $13.1M in private sale at bizjournals.com -5.68%
06:00AM  A.P. Pharma Announces Private Equity Placement Business Wire
30-Sep-09 04:58PM  AP PHARMA INC /DE/ Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
21-Sep-09 11:54AM  AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard EDGAR Online
10:05AM  AP Pharma faces delisting in six months at bizjournals.com
06:00AM  A.P. Pharma Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule Business Wire
18-Sep-09 04:38PM  AP PHARMA INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online -6.82%
15-Sep-09 10:05AM  A.P. Pharma, Merial in license agreement at bizjournals.com +6.02%
06:00AM  A.P. Pharma and Merial Enter into Worldwide Agreement Business Wire
05-Aug-09 03:17PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online -8.05%
04-Aug-09 03:43PM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
10:05AM  A.P. Pharma pares Q2 loss down to $3.9M at bizjournals.com
06:00AM  A.P. Pharma Reports Second Quarter 2009 Financial Results Business Wire
20-Jul-09 04:44PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
10:05AM  AP Pharma gets Nasdaq warning at bizjournals.com
06:18AM  A. P. Pharma gets Nasdaq non-compliance notice at MarketWatch
06:05AM  A.P. Pharma Announces FDA Acceptance of APF530 New Drug Application for Chemotherapy-Induced Nausea and Vomiting Business Wire
06:00AM  A.P. Pharma Receives Nasdaq Notice of Non-Compliance; Company to Request Hearing Business Wire
28-Jun-09 04:50AM  FDA Extreme Trades: 16 Stocks Under 5 Bucks at Seeking Alpha
03-Jun-09 03:24PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events EDGAR Online +5.88%
06:00AM  A.P. Pharma Receives Extension for Nasdaq Listing Compliance Business Wire
02-Jun-09 03:17PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events EDGAR Online -13.27%
03:38AM  13 Extreme FDA Trades at Seeking Alpha
01-Jun-09 06:00AM  A.P. Pharma Presents APF530 Phase 3 Data at Annual Meeting of the American Society of Clinical Oncology Business Wire +10.11%
31-May-09 06:38AM  Two Potential Mega Biotech Deals Fuel Industry Hopes at Seeking Alpha
29-May-09 09:05AM  A.P. Pharma cutting more employees at bizjournals.com
09:05AM  A.P. Pharma cutting more employees at bizjournals.com
06:00AM  A.P. Pharma Announces Additional Restructuring Effort Business Wire
20-May-09 01:25PM  AP PHARMA INC /DE/ Files SEC form 8-K, Other Events EDGAR Online +12.70%
18-May-09 06:02AM  A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting Business Wire +11.11%
06:00AM  APF530 Phase 3 Data for Chemotherapy-Induced Nausea and Vomiting to be Presented at American Society of Clinical Oncology 2009 Annual Meeting Business Wire
17-May-09 09:33AM  New Star Analyst Rankings for A.P. Pharma, Inc. StarMine
15-May-09 03:52PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
14-May-09 04:33PM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online -10.00%
06:00AM  A.P. Pharma Reports First Quarter 2009 Financial Results Business Wire
08-May-09 06:39AM  Zacks #1 Rank Additions for Friday Zacks.com +15.25%
10-Apr-09 12:29PM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08-Apr-09 12:40PM  AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard EDGAR Online -12.73%
07-Apr-09 11:05AM  AP Pharma gets Nasdaq delisting warning at bizjournals.com
06:00AM  A.P. Pharma Receives Nasdaq Stockholder Equity Notification Business Wire
03-Apr-09 07:06AM  Zacks #1 Rank Additions for Friday Zacks.com
01-Apr-09 12:46PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
31-Mar-09 10:05AM  A.P. Pharma narrows Q4 loss to $3.9M at bizjournals.com -15.62%
06:05AM  AP PHARMA INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online
06:00AM  A.P. Pharma Announces Fourth Quarter and Year-End 2008 Financial Results and Provides Update on APF530 NDA Business Wire
26-Feb-09 11:47AM  Latest News in Activist Investing at TheStreet.com
25-Feb-09 12:49PM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
06:00AM  A.P. Pharma Appoints John B. Whelan as Chief Financial Officer Business Wire
09-Feb-09 05:06PM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +6.06%
18-Dec-08 06:00AM  A.P. Pharma Revises Target Date for APF530 NDA Business Wire
07-Nov-08 03:55PM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online +16.00%
06-Nov-08 12:06AM  A.P. Pharma cuts 18 people, posts loss at bizjournals.com
05-Nov-08 05:16PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or D EDGAR Online
03:20PM  Small drug developers cut jobs to save cash in crunch at Reuters
12:05PM  A.P. Pharma Q3 loss widens, cuts staff at bizjournals.com
07:33AM  UPDATE - A.P. Pharma posts wider Q3 loss, cuts jobs at Reuters
07:07AM  Q3 2008 A.P. Pharma Inc. Earnings Release - Before Market Open CCBN
06:00AM  A.P. Pharma Reports Results for the Third Quarter 2008 Business Wire
03-Nov-08 08:00AM  A.P. Pharma to Present at Rodman & Renshaw 10th Annual Healthcare Conference on November 12 Business Wire
29-Oct-08 03:20PM  A.P. Pharma to Hold 2008 Third Quarter Financial Results Conference Call November 5 Business Wire
03:20PM  A.P. Pharma to Hold 2008 Third Quarter Financial Results Conference Call November 5 Business Wire
07-Oct-08 02:18PM  AP PHARMA INC /DE/ Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial Statements and EDGAR Online +6.76%
03-Oct-08 12:47PM  Insider Action: Trading Level 3 at TheStreet.com +20.00%
30-Sep-08 02:35PM  Metabolex adds QuatRx CEO to board at bizjournals.com -34.78%
12:15PM  A.P. Pharma nausea treatment tests well at bizjournals.com
07:19AM  UPDATE - A.P. Pharma drug fails to meet superiority goal at Reuters
04:00AM  A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV Business Wire
29-Sep-08 04:05PM  A.P. Pharma to Hold APF530 Phase 3 Trial Results Conference Call September 30 at 9:00 a.m. Eastern Business Wire -6.50%
10-Sep-08 01:33PM  Coverage initiated on AP Pharma by Ladenburg Thalmann Briefing.com
14-Aug-08 02:45PM  A.P. Pharmas Q2 loss grows to $6.1 million at bizjournals.com
01:07PM  AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
09:25AM  A.P. Pharma Q2 loss grows to $6.1M at bizjournals.com
07:07AM  Q2 2008 A.P. Pharma Inc. Earnings Release - Before Market Open CCBN
04:00AM  A.P. Pharma Reports Results for the Second Quarter 2008 Business Wire
31-Jul-08 12:20PM  A.P. Pharma to Hold 2008 Second Quarter Financial Results Conference Call August 14 Business Wire
09-Jul-08 04:05PM  A.P. Pharma Announces Stock Option Grant Business Wire
04:03PM  AP PHARMA INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
07-Jul-08 04:25PM  A.P. Pharma names president, CEO at bizjournals.com
04:25PM  A.P. Pharma hires CEO at bizjournals.com
04:05PM  A.P. Pharma Appoints Ronald J. Prentki as President, Chief Executive Officer and Member of Its Board of Directors Business Wire
23-Jun-08 11:45AM  A.P. Pharma fills up clinical trial of nausea drug at bizjournals.com -8.73%
07:00AM  A.P. Pharma Completes Enrollment in Phase 3 Trial of APF530 Business Wire
15-May-08 12:51PM  AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online +7.41%
A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its lead product candidate is APF530, which completed pivotal Phase III clinical trial for the prevention of chemotherapy-induced nausea and vomiting. The company's product candidate also includes APF112, which incorporates anesthetic, mepivacaine and is designed to provide relief from post-surgical pain and to minimize the use of morphine-like drugs, or opiates. Its pre clinical product candidate APF580 incorporates an opiate into its Biochronomer technology and is designed to provide analgesia lasting at least seven days from a single injection. A.P. Pharma's Biochronomer technology is also used for various applications in therapeutic areas, including pain management, prevention of nausea, control of inflammation, and treatment of ophthalmic diseases. The company was formerly known as Advanced Polymer Systems, Inc. and changed its name to A.P. Pharma, Inc. in May 2001. A.P. Pharma, Inc. was founded in 1983 and is based in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TANG KEVIN CDirectorOct 19Buy0.882,443,1812,149,99910,436,506Oct 21 06:40 PM